A seven-time Olympic medalist was diagnosed with ovarian cancer after missing the same three warning signs common in early ...
Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...
BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall survival (OS) benefit in ovarian cancer, phase III study results showed.
KEYNOTE-B96 is the first trial to show overall survival (OS) improvement with an immune checkpoint inhibitor-based treatment ...